Comparison Overview

SARSTEDT Group

VS

Stryker

SARSTEDT Group

Sarstedtstraße 1, Nümbrecht, NRW, 51588, DE
Last Update: 2025-03-07 (UTC)
Between 900 and 1000

Excellent

We develop, produce and sell devices and consumables for medicine and science. SARSTEDT is known as one of the leading providers in this sector worldwide. Ever since the company’s foundation in 1961, we have continued to grow to the point where we now employ a workforce of 2,900. Our SARSTEDT Group with its head office in Nümbrecht (Germany), North Rhine-Westphalia, comprises 34 sales organisations and 14 production sites in Europe, Australia, North and South America. Quality "Made in Germany"​ Our customers can rely on high-quality and high-performance products. "We always develop solutions characterised by ease of use, safety and the latest technology,"​ highlights the Sarstedt family, who own the Group. In order to continue to ensure this in the future, sustainable and intensive investments have been made in our national and international locations in the past few years. The high demand for quality, continuous development work, committed and very well trained employees and automated processes are the components which make up our excellent quality "Made in Germany”. We offer services under one roof – from the initial idea through to sales. The majority of our products are developed in our Development Centre. Approximately 90 per cent of our products are manufactured at our own production sites and sold around the world for the most part through our own sales organisations. In this way, we are able to achieve the highest level of quality, delivery capability and product support all under one roof. As a responsibly managed family-owned company, we feel obliged to act beyond our business objective to the benefit of society. Our products increase patient and user comfort, make laboratory work more efficient and, in this way, help to improve healthcare worldwide in the long term.

NAICS: 339
NAICS Definition:
Employees: 676
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Stryker

2825 Airview Boulevard, None, Kalamazoo, MI, US, 49002
Last Update: 2025-08-05 (UTC)

Strong

Between 800 and 900

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2023 Sales: $20.5 billion ● Industry: Medical Instruments & Supplies ● Employees: 52,000 worldwide ● 40 years of sales growth leading up to 2020 ● 44+ Manufacturing and R&D Locations Worldwide ● $1.4 billion spent on research and development in 2023 ● ~12,900 patents owned globally in 2023 ● Products sold in ~75 countries ● Fortune 500 Company ● 7 consecutive years as one of Fortune's World's Best Workplaces Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 47,772
Subsidiaries: 39
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sarstedt-group.jpeg
SARSTEDT Group
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/stryker.jpeg
Stryker
ISO 27001
Not verified
SOC 2
Not verified
GDPR
No public badge
PCI DSS
No public badge
Compliance Summary
SARSTEDT Group
100%
Compliance Rate
0/4 Standards Verified
Stryker
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for SARSTEDT Group in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Stryker in 2025.

Incident History — SARSTEDT Group (X = Date, Y = Severity)

SARSTEDT Group cyber incidents detection timeline including parent company and subsidiaries

Incident History — Stryker (X = Date, Y = Severity)

Stryker cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sarstedt-group.jpeg
SARSTEDT Group
Incidents

No Incident

https://images.rankiteo.com/companyimages/stryker.jpeg
Stryker
Incidents

Date Detected: 5/2024
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

SARSTEDT Group company company demonstrates a stronger AI risk posture compared to Stryker company company, reflecting its advanced AI governance and monitoring frameworks.

Stryker company has historically faced a number of disclosed cyber incidents, whereas SARSTEDT Group company has not reported any.

In the current year, Stryker company and SARSTEDT Group company have not reported any cyber incidents.

Neither Stryker company nor SARSTEDT Group company has reported experiencing a ransomware attack publicly.

Stryker company has disclosed at least one data breach, while SARSTEDT Group company has not reported such incidents publicly.

Neither Stryker company nor SARSTEDT Group company has reported experiencing targeted cyberattacks publicly.

Neither SARSTEDT Group company nor Stryker company has reported experiencing or disclosing vulnerabilities publicly.

Stryker company has more subsidiaries worldwide compared to SARSTEDT Group company.

Stryker company employs more people globally than SARSTEDT Group company, reflecting its scale as a Medical Equipment Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

Volto is a ReactJS-based frontend for the Plone Content Management System. Versions 16.34.0 and below, 17.0.0 through 17.22.1, 18.0.0 through 18.27.1, and 19.0.0-alpha.1 through 19.0.0-alpha.5, an anonymous user could cause the NodeJS server part of Volto to quit with an error when visiting a specific URL. This issue is fixed in versions 16.34.1, 17.22.2, 18.27.2 and 19.0.0-alpha.6.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Traccar is an open source GPS tracking system. Default installs of Traccar on Windows between versions 6.1- 6.8.1 and non default installs between versions 5.8 - 6.0 are vulnerable to unauthenticated local file inclusion attacks which can lead to leakage of passwords or any file on the file system including the Traccar configuration file. Versions 5.8 - 6.0 are only vulnerable if <entry key='web.override'>./override</entry> is set in the configuration file. Versions 6.1 - 6.8.1 are vulnerable by default as the web override is enabled by default. The vulnerable code is removed in version 6.9.0.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Stalwart is a mail and collaboration server. Versions 0.13.3 and below contain an unbounded memory allocation vulnerability in the IMAP protocol parser which allows remote attackers to exhaust server memory, potentially triggering the system's out-of-memory (OOM) killer and causing a denial of service. The CommandParser implementation enforces size limits on its dynamic buffer in most parsing states, but several state handlers omit these validation checks. This issue is fixed in version 0.13.4. A workaround for this issue is to implement rate limiting and connection monitoring at the network level, however this does not provide complete protection.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

WeGIA is an open source web manager with a focus on charitable institutions. Versions 3.4.12 and below contain a Broken Access Control vulnerability, identified in the get_relatorios_socios.php endpoint. This vulnerability allows unauthenticated attackers to directly access sensitive personal and financial information of members without requiring authentication or authorization. This issue is fixed in version 3.5.0.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

WeGIA is an open source web manager with a focus on charitable institutions. Versions 3.4.12 and below contain an Open Redirect vulnerability, identified in the control.php endpoint, specifically in the nextPage parameter (metodo=listarUmnomeClasse=FuncionarioControle). This vulnerability allows attackers to redirect users to arbitrary external domains, enabling phishing campaigns, malicious payload distribution, or user credential theft. This issue is fixed in version 3.5.0.

Risk Information
cvss4
Base: 4.8
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X